search
Back to results

Prevention of Hypergranulation Tissue After Gastrostomy Tube Placement

Primary Purpose

Soft Tissue Inflammation

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Standard Hydrocolloid Dressing
Silver Hydrocolloid Dressing
Sponsored by
Ann & Robert H Lurie Children's Hospital of Chicago
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Soft Tissue Inflammation focused on measuring Hypergranulation tissue, Gastrostomy tube, Hydrocolloid dressing, Silver hydrocolloid dressing, Gastrostomy tube dislodgement, Wound infection, Peristomal skin breakdown

Eligibility Criteria

1 Month - 17 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Children between 1 month and 17 years of age who undergo gastrostomy tube placement by a member of the pediatric surgery faculty at Children's Memorial Hospital will be eligible for inclusion in this study.

Exclusion Criteria:

  • Children undergoing gastrostomy tube placement by gastroenterology or interventional radiology at Children's Memorial Hospital.
  • Mother or caregiver of the patient is currently pregnant, breastfeeding and/or planning on getting pregnant within the next 60 days (silver HD has not been studied in pregnant or breastfeeding women)

Sites / Locations

  • Children's Memorial Hospital

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

No Intervention

Experimental

Experimental

Arm Label

Standard postop gastrostomy tube care

Standard hydrocolloid dressing

Silver hydrocolloid dressing

Arm Description

At the completion of the operative procedure for gastrostomy tube placement, the surgical incisions and the gastrostomy tube will be covered with dermabond, steristrips, and/or tegaderm dressings, according to surgeon preference. Standard postop gastrostomy tube care. Insertion site cleaned with soap and water. No dressing added.

At the completion of the operative procedure for gastrostomy tube placement, the surgical incisions will be covered with dermabond, steristrips, and/or tegaderm dressings, according to the surgeons preference. The gastrostomy tube will have a thin layer of hydrocolloid dressing (HD) placed around the gastrostomy tube. The HD will be changed once every other day fo the first 30 days after gastrostomy tube placement. After 30 days, care will revert to standard care.

At the completion of the operative procedure for gastrostomy tube placement, the surgical incisions will be covered with dermabond, steristrips, and/or tegaderm dressings, according to surgeon preference. The gastrostomy tube will have a thin layer of silver hydrocolloid dressing (HD) placed around the gastrostomy tube. The silver HD will be changed once every other day for the first 30 days after gastrostomy tube placement. After 30 days, care will revert to standard care.

Outcomes

Primary Outcome Measures

The primary outcome is to measure change in Hypergranulation tissue formation around Gastrostomy tube.

Secondary Outcome Measures

The secondary outcome is to measure change in visual assessment of postoperative condition of gastrostomy tube insertion site.

Full Information

First Posted
December 20, 2011
Last Updated
February 6, 2018
Sponsor
Ann & Robert H Lurie Children's Hospital of Chicago
search

1. Study Identification

Unique Protocol Identification Number
NCT01501539
Brief Title
Prevention of Hypergranulation Tissue After Gastrostomy Tube Placement
Official Title
Prevention of Hypergranulation Tissue After Gastrostomy Tube Placement: A Randomized Controlled Trial of Hydrocolloid Dressings
Study Type
Interventional

2. Study Status

Record Verification Date
February 2018
Overall Recruitment Status
Completed
Study Start Date
December 2010 (undefined)
Primary Completion Date
June 2017 (Actual)
Study Completion Date
June 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Ann & Robert H Lurie Children's Hospital of Chicago

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The primary objective of this study is to compare the incidence of postoperative hypergranulation tissue formation after gastrostomy tube placement among children randomized to one of three treatments, in addition to measuring tube dislodgements and rates of resource utilization for complications.
Detailed Description
Hypergranulation tissue is one of the major immediate complications of gastronomy tube placement. This study aims to determine if using a foam dressing upon placement will prevent its formation, as it has been demonstrated as an effective treatment in healing hypergranulation tissue formation post-operatively. Study participants will be randomized into one of three treatments after gastronomy tube placement (1) standard care, (2) plain foam treatment or (3) silver foam dressing. These treatments will be applied for 30 days post-operatively in addition to standard care of cleaning the gastronomy site daily with soap and water, if assigned to foam intervention. All study materials are free for duration of 30 day intervention and participation will not interfere with routine post-operative care of gastronomy tube site. The total duration of trial will be 6 months and will not require additional study visits outside of routine care. The rate of G-tube dislodgements and associated outcomes will also be measured during the trial.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Soft Tissue Inflammation
Keywords
Hypergranulation tissue, Gastrostomy tube, Hydrocolloid dressing, Silver hydrocolloid dressing, Gastrostomy tube dislodgement, Wound infection, Peristomal skin breakdown

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
171 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Standard postop gastrostomy tube care
Arm Type
No Intervention
Arm Description
At the completion of the operative procedure for gastrostomy tube placement, the surgical incisions and the gastrostomy tube will be covered with dermabond, steristrips, and/or tegaderm dressings, according to surgeon preference. Standard postop gastrostomy tube care. Insertion site cleaned with soap and water. No dressing added.
Arm Title
Standard hydrocolloid dressing
Arm Type
Experimental
Arm Description
At the completion of the operative procedure for gastrostomy tube placement, the surgical incisions will be covered with dermabond, steristrips, and/or tegaderm dressings, according to the surgeons preference. The gastrostomy tube will have a thin layer of hydrocolloid dressing (HD) placed around the gastrostomy tube. The HD will be changed once every other day fo the first 30 days after gastrostomy tube placement. After 30 days, care will revert to standard care.
Arm Title
Silver hydrocolloid dressing
Arm Type
Experimental
Arm Description
At the completion of the operative procedure for gastrostomy tube placement, the surgical incisions will be covered with dermabond, steristrips, and/or tegaderm dressings, according to surgeon preference. The gastrostomy tube will have a thin layer of silver hydrocolloid dressing (HD) placed around the gastrostomy tube. The silver HD will be changed once every other day for the first 30 days after gastrostomy tube placement. After 30 days, care will revert to standard care.
Intervention Type
Procedure
Intervention Name(s)
Standard Hydrocolloid Dressing
Other Intervention Name(s)
FDA Class II-K medical products, Hollister Wound Care (Hollister Incorporated)
Intervention Description
Treatment placed over insertion site.
Intervention Type
Procedure
Intervention Name(s)
Silver Hydrocolloid Dressing
Other Intervention Name(s)
FDA Class II-K medical products, Hollister Wound Care (Hollister Incorporated)
Intervention Description
Place dressing against skin under gastrostomy tube
Primary Outcome Measure Information:
Title
The primary outcome is to measure change in Hypergranulation tissue formation around Gastrostomy tube.
Time Frame
2 time points: 2 weeks and 6 months post insertion.
Secondary Outcome Measure Information:
Title
The secondary outcome is to measure change in visual assessment of postoperative condition of gastrostomy tube insertion site.
Time Frame
2 timepoints: 2 weeks and 6 months post insertion.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
1 Month
Maximum Age & Unit of Time
17 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Children between 1 month and 17 years of age who undergo gastrostomy tube placement by a member of the pediatric surgery faculty at Children's Memorial Hospital will be eligible for inclusion in this study. Exclusion Criteria: Children undergoing gastrostomy tube placement by gastroenterology or interventional radiology at Children's Memorial Hospital. Mother or caregiver of the patient is currently pregnant, breastfeeding and/or planning on getting pregnant within the next 60 days (silver HD has not been studied in pregnant or breastfeeding women)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Katherine A Barsness, MD
Organizational Affiliation
Ann & Robert H Lurie Children's Hospital of Chicago
Official's Role
Principal Investigator
Facility Information:
Facility Name
Children's Memorial Hospital
City
Chicago
State/Province
Illinois
ZIP/Postal Code
60614
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Prevention of Hypergranulation Tissue After Gastrostomy Tube Placement

We'll reach out to this number within 24 hrs